• Mashup Score: 31
    Hostile vascular access for large catheters - 7 month(s) ago

    This case-based session will help you learn how to better manage ilio-vascular complications, either by radial or femoral access, and learn more about how to use your peripheral toolbox.

    Source: www.pcronline.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of PCRonline
      PCRonline

      Hostile vascular access for large catheters Learn how to better manage ilio-vascular complications, either by radial or femoral access, and extend your knowledge with this #peripheral toolbox 🧰 shared by Antoine Sauguet! Access slides 📑https://t.co/f3zscVfNUK #cardiotwitter… https://t.co/ZMPVtDUkZe https://t.co/LFkHUYpFeY

  • Mashup Score: 0
    SCAI 2023 Fellows Courses | SCAI - 8 month(s) ago

    SCAI’s Fellows Courses teach future generations of interventional cardiologists the knowledge and skills they need for post-fellowship practice. If you are a current interventional cardiology fellow or are in, or have been accepted to, an advanced training program, explore which of the following four courses is the right one for you: All four courses are taught by an internationally recognized faculty in an engaging, collegial environment and scholarships are available for all fellows whose applications

    Source: scai.org
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SCAI
      SCAI

      Calling all IC Fellows—choose from 4 courses at #SCAIFellows tailored to your educational needs: ✔️#Interventional Cardiology ✔️#Congenital Heart Disease ✔️Advanced #Peripheral Vascular ✔️Advanced #Structural Heart Disease Apply for scholarship today ➡️ https://t.co/CAVvX45SeH https://t.co/IEPkYosZ2S

  • Mashup Score: 7
    Cooling and Compression to Prevent Peripheral Neuropathy (Nerve Damage) During Chemotherapy | SWOG - 10 month(s) ago

    Clinical Trial Summary (S2205) What is the purpose of this clinical trial? This study tests how to prevent a side effect of chemotherapy called peripheral neuropathy. Peripheral neuropathy is a nerve problem that can cause numbness, tingling, or pain in the arms and legs. This study uses a machine that cools and…

    Source: www.swog.org
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of SWOG
      SWOG

      S2205 is a study about preventing nerve damage (#peripheral #neuropathy) from chemo treatment. You may be able to join if you’ll be receiving #chemotherapy that uses taxane drugs (such as paclitaxel and docetaxel). Learn more at https://t.co/qs8FRXyAM0. Or call 1-800-4-CANCER. https://t.co/IlPUlPpLJ5

  • Mashup Score: 0
    Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality - 10 month(s) ago

    July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information associated with paclitaxel-coated devices used to treat peripheral arterial disease (PAD). Based on the FDA’s review of the totality of the available data and analyses, it has determined that the data does not support an excess mortality risk for paclitaxel-coated devices. The…

    Source: DAIC
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DAICeditor
      DAICeditor

      @DAICeditor @FDADeviceInfo The U.S. Food and Drug Administration (#FDA) has issued a Letter to #HealthCare Providers about updated information associated with #paclitaxel-coated devices used to treat #peripheral #arterial #disease (#PAD): https://t.co/1owQZPwQD0

  • Mashup Score: 0
    Endologix Receives FDA Approval of the DETOUR System to Treat Long Complex Superficial Femoropopliteal Lesions in Patients with PAD - 10 month(s) ago

    June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted approval for the DETOUR System to treat patients with complex peripheral arterial disease (PAD).  Over 8.5 million Americans are affected by PAD. This…

    Source: DAIC
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DAICeditor
      DAICeditor

      @DAICeditor @endologix Endologix announced that the U.S. Food and Drug Administration (#FDA) has granted approval for the #DETOUR System to treat patients with complex #peripheral #arterial #disease (#PAD): https://t.co/yonbOUljKt

Load More